CELG

Celgene Corporation News Headlines

$96.55
*  
1.58
1.66%
Get CELG Alerts
*Delayed - data as of Oct. 22, 2014 10:43 ET  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CELG Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Biotech Stock Roundup: Amgen Data Looks Good, CANF Tumbles - Industry Outlook
1/8/2014 10:17:00 AM - Investopedia


Top Funds Like Facebook And Health Care Stocks
1/7/2014 7:59:00 PM - Investor's Business Daily


Closing Update: Stocks Snap Back To 2013 Levels on Bullish Trade Data
1/7/2014 5:09:15 PM - MT Newswires


Healthcare Stocks Ending With Broad Gains; Stereotaxis Rises After Completing Clinical Trial of Surgical Device
1/7/2014 4:53:14 PM - MT Newswires


Sector Update: Healthcare
1/7/2014 4:52:27 PM - MT Newswires


Healthcare Stocks Pacing Market Gains; Community Health Rising on Strong FY14 Revenue Outlook
1/7/2014 3:52:16 PM - MT Newswires


Sector Update: Healthcare
1/7/2014 3:47:47 PM - MT Newswires


Midday Update: Equities Back on the Offensive Following Strong U.S. Trade Data
1/7/2014 1:33:15 PM - MT Newswires


Stocks To Open Higher But Yesterday's Weak ISM Still Weighs
1/7/2014 10:08:39 AM - MT Newswires


Cramer's Mad Money - The Worst S&P 500 Stocks Of 2013 (1/6/14)
1/7/2014 5:58:00 AM - Seeking Alpha


Celgene's Stock Should See New All-Time Highs Due To Strong Pipeline
1/3/2014 2:14:00 PM - Seeking Alpha


Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
1/3/2014 10:12:00 AM - Seeking Alpha


Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
12/30/2013 1:30:00 AM - Seeking Alpha


Neostem Stands To Benefit From Stem-Cell Deals
12/23/2013 9:20:00 AM - Seeking Alpha


Cramer's Mad Money - Themes That Will Work For 2014 (12/19/13)
12/20/2013 6:23:00 AM - Seeking Alpha


Epizyme: Exciting Science, Exciting Investment Opportunity
12/19/2013 12:41:00 PM - Seeking Alpha


Ziopharm: Finally A Winner In The War On Cancer?
12/15/2013 1:22:00 PM - Seeking Alpha


Follow The Money
12/12/2013 5:23:00 AM - Seeking Alpha


Biotech Stock Roundup: GILD Scores FDA Approval, Ambit Plunges - Analyst Blog
12/11/2013 11:24:55 AM - Zacks.com


Celgene Rises on Positive Revlimid Data - Analyst Blog
12/10/2013 6:20:01 PM - Zacks.com


Data Presented by Celgene - Analyst Blog
12/9/2013 1:07:39 PM - Zacks.com


OncoMed Progresses with Oncology Candidate - Analyst Blog
12/5/2013 6:50:01 PM - Zacks.com


Celgene Joins Forces with OncoMed - Analyst Blog
12/4/2013 12:50:01 PM - Zacks.com


Biotech Stock Roundup: CBST Hits 52-Week High, OREX Lights Up - Analyst Blog
12/4/2013 11:59:01 AM - Zacks.com


Healthcare Stocks Mostly Lower Near Bell; OncoMed Soars Following Collaboration Pact with Celgene
12/3/2013 4:56:19 PM - MT Newswires